Thomas Ryckewaert Selected Research

Thomas Ryckewaert Research Topics

7	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 01/2015
6	Neoplasms (Cancer) 01/2022 - 07/2015
4	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2017
3	Renal Cell Carcinoma (Grawitz Tumor) 10/2022 - 06/2019
3	Leiomyosarcoma 10/2020 - 01/2018
2	Hemangiosarcoma (Angiosarcoma) 01/2022 - 10/2018
2	Aggressive Fibromatosis (Desmoid) 01/2020 - 11/2019
2	Fibroma (Fibromatosis) 01/2020 - 11/2019
1	Phyllodes Tumor (Cystosarcoma Phylloides) 05/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Myxoma (Myxomas) 11/2019
1	Adenosarcoma 11/2019
1	Endometrial Stromal Sarcoma 11/2019
1	Brain Neoplasms (Brain Tumor) 06/2019
1	Synovial Sarcoma (Synovioma) 01/2018
1	Liposarcoma 01/2018
1	Brain Diseases (Brain Disorder) 03/2017
1	Prostatic Neoplasms (Prostate Cancer) 09/2015
1	Chordoma 07/2015
1	Neutropenia 03/2015

2	NivolumabIBA 10/2022 - 01/2022
2	Ifosfamide FDA LinkGeneric 10/2020 - 03/2017
2	regorafenibIBA 01/2020 - 01/2018
2	TrabectedinIBA 03/2015 - 01/2015
1	cabozantinibIBA 10/2022
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	IpilimumabIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Alkylating AgentsIBA 05/2020
1	pazopanib FDA Link 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	Estrogens (Estrogen)FDA Link 11/2019
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 11/2019
1	Progestins (Progestagens)IBA 11/2019
1	Estrogen ReceptorsIBA 11/2019
1	Aromatase InhibitorsIBA 11/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2018
1	Bevacizumab (Avastin)FDA Link 10/2018
1	Vascular Endothelial Growth Factor CIBA 10/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Programmed Cell Death 1 ReceptorIBA 01/2018
1	Biological ProductsIBA 03/2017
1	Docetaxel (Taxotere)FDA Link 09/2015
1	Pharmaceutical PreparationsIBA 07/2015
1	Imatinib Mesylate (Gleevec)FDA Link 07/2015
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2015
1	Alanine Transaminase (SGPT)IBA 03/2015

6	Therapeutics 01/2022 - 01/2015
5	Drug Therapy (Chemotherapy) 01/2022 - 03/2015
1	Adjuvant Chemotherapy 01/2022
1	Immunotherapy 01/2018
1	Palliative Care (Palliative Therapy) 09/2015
1	Molecular Targeted Therapy 07/2015